Details for New Drug Application (NDA): 211518
✉ Email this page to a colleague
The generic ingredient in BENZONATATE is benzonatate. There are six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the benzonatate profile page.
Summary for 211518
Tradename: | BENZONATATE |
Applicant: | Ascent Pharms Inc |
Ingredient: | benzonatate |
Patents: | 0 |
Pharmacology for NDA: 211518
Physiological Effect | Decreased Tracheobronchial Stretch Receptor Activity |
Suppliers and Packaging for NDA: 211518
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BENZONATATE | benzonatate | CAPSULE;ORAL | 211518 | ANDA | Camber Pharmaceuticals, Inc. | 31722-956 | 31722-956-01 | 100 CAPSULE in 1 BOTTLE (31722-956-01) |
BENZONATATE | benzonatate | CAPSULE;ORAL | 211518 | ANDA | Camber Pharmaceuticals, Inc. | 31722-956 | 31722-956-05 | 500 CAPSULE in 1 BOTTLE (31722-956-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Feb 22, 2019 | TE: | AA | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 150MG | ||||
Approval Date: | Feb 22, 2019 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Feb 22, 2019 | TE: | AA | RLD: | No |
Complete Access Available with Subscription